
April 2007
Advertisement
Advertisement
Trending on AJMC
1
Communication of Launch Prices by Drug Companies, 2022-2024
2
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
3
Top 5 Most-Read News Stories of 2025
4
Bispecifics in New Combos, New Uses, and Earlier Lines of Treatment in Myeloma
5



